Biological therapies including IFN-α have shown a real, but minimal, effect in malignant melanomas (Pavlick et al, 2003) and the effects of IL-2, as a treatment for malignant melanoma, are not yet clearly defined. The gene discussed is IL2; the disease is melanoma.